Latest Articles

Publication Date
Cartherics and Zucker Institute execute research collaboration and option agreement to combine iPSC-derived NK cell platform with novel anti-tissue factor antibody – News Hub - Medianet News Hub

Cartherics and Zucker Institute execute research collaboration and option agreement to combine iPSC-derived NK cell platform with novel anti-tissue factor antibody – News Hub Medianet News Hub

Published: Sept. 1, 2026, 12:29 a.m.
Cartherics and Zucker Institute execute research collaboration and option agreement to combine iPSC-derived NK cell platform with novel anti-tissue factor antibody – News Hub - newshub.medianet.com.au

Cartherics and Zucker Institute execute research collaboration and option agreement to combine iPSC-derived NK cell platform with novel anti-tissue factor antibody – News Hub newshub.medianet.com.au

Published: Sept. 1, 2026, 12:29 a.m.
L-ICON3 Suppresses Endometriosis in a Murine Model.

Endometriosis is a chronic, systemic gynecological disorder that affects 190 million women worldwide. Current treatments consist of hormonal suppression and surgical excision; however, both have considerable side effects and a …

Published: Aug. 27, 2026, midnight
Breaking the endometriosis-stroke axis: lesion-focused hydrogel reprogramming of thromboinflammatory networks.

Endometriosis is a chronic, systemic inflammatory disorder characterized by the ectopic implantation of endometrial-like tissue and accompanied by persistent pain and infertility. Beyond the pelvis, accumulating epidemiological evidence indicates that …

Published: June 8, 2026, midnight
Impact of Estetrol Combined with Drospirenone on Blood Coagulation and Fibrinolysis in Patients with Endometriosis: A Multicenter, Randomized, Open-Label, Active-Controlled, Parallel-Group Study.

Venous thromboembolism is a serious safety concern in women using combined oral contraceptives; ethinyl estradiol (EE) is widely used as an estrogen. Estetrol (E4) is a native estrogen with selective …

Published: Oct. 13, 2024, 4:35 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!